Loading...
BCAL Diagnostics Limited
BDX.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$0.06
A$-0.00(-3.45%)
BCAL Diagnostics Limited (BDX.AX) Financial Performance & Income Statement Overview
Review BCAL Diagnostics Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.60%
↑ 8.60%
Operating Income Growth
31.03%
↑ 31.03%
Net Income Growth
-26.44%
↓ 26.44%
Operating Cash Flow Growth
25.21%
↑ 25.21%
Operating Margin
-255.15%
↓ 255.15%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-304.89%
↓ 304.89%
ROE
-89.51%
↓ 89.51%
ROIC
-66.16%
↓ 66.16%
BCAL Diagnostics Limited (BDX.AX) Income Statement & Financial Overview
Review BCAL Diagnostics Limited's (BDX.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.24M | $930857.00 | $922528.00 | $922528.00 |
| Cost of Revenue | $1.00 | $269307.00 | $0.00 | $0.00 |
| Gross Profit | $1.24M | $661550.00 | $922528.00 | $922528.00 |
| Gross Profit Ratio | $1.00 | $0.71 | $1.00 | $1.00 |
| R&D Expenses | $2.32M | $2.05M | $2.13M | $1.06M |
| SG&A Expenses | $2.42M | $1.90M | $2.29M | $963182.00 |
| Operating Expenses | $4.74M | $3.95M | $4.42M | $2.21M |
| Total Costs & Expenses | $4.74M | $4.21M | $4.42M | $2.21M |
| Interest Income | $49005.00 | $2387.00 | $29787.00 | $8020.00 |
| Interest Expense | $46466.00 | $53461.00 | $16039.00 | $0.00 |
| Depreciation & Amortization | $90854.00 | $269307.00 | $14677.00 | $5152.00 |
| EBITDA | -$3.72M | -$3.94M | -$4.39M | -$1.16M |
| EBITDA Ratio | -$3.008 | -$4.24 | -$1.24 | -$1.25 |
| Operating Income | -$3.50M | -$4.21M | -$4.42M | -$1.16M |
| Operating Income Ratio | -$2.83 | -$4.53 | -$4.79 | -$1.26 |
| Other Income/Expenses (Net) | -$494750.00 | -$51074.00 | -$3.28M | -$170932.00 |
| Income Before Tax | -$3.99M | -$4.27M | -$4.41M | -$1.30M |
| Income Before Tax Ratio | -$3.23 | -$4.58 | -$4.78 | -$1.40 |
| Income Tax Expense | $0.00 | -$1.86M | -$1.82M | $0.00 |
| Net Income | -$3.99M | -$2.41M | -$2.59M | -$1.30M |
| Net Income Ratio | -$3.23 | -$2.59 | -$2.81 | -$1.40 |
| EPS | -$0.02 | -$0.01 | -$0.01 | -$0.006 |
| Diluted EPS | -$0.02 | -$0.01 | -$0.01 | -$0.006 |
| Weighted Avg Shares Outstanding | $260.96M | $231.40M | $212.31M | $210.64M |
| Weighted Avg Shares Outstanding (Diluted) | $261.05M | $231.40M | $212.31M | $210.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan